Comments
The Pharmaceuticals Export Promotion Council (Pharmexcil) is working with the Government and industry to put in place substitute mechanism for Chinese imports.
“We are requesting the Government to take steps to facilitate manufacturing of top 100 products, which are at present being imported from China, in India itself,’’ M Madan Mohan Reddy, Chairman Pharmexcil and Director, Aurobindo Pharma Ltd, told newspersons here on Tuesday.
He was speaking during a curtain-raiser press conference on the pharma event CPhI & P-MEC to be held in Mumbai during November 17-23.
When asked on the quantum of imports from China, Reddy said chemicals and intermediates worth $3.2 billion were being imported from China. “A cluster-based approach to manufacture these products will be useful,’’ he added.
Pharma exports are likely to grow between 10 and 12 per cent this year, Reddy said adding that ‘huge opportunity’ will be created for Indian drug-makers with many patents set to expire in the coming years.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.